Visualize, quantify, and phenotype in situ in FFPE tissue sections and TMAs
Please log in for more information
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure.
Revvity is pushing the limits of what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With a robust global network and localized agility, we serve a diverse range of organizations from pharmaceutical and biotech, to clinical labs, academia, and governments.
Together with our customers and partners, we are united in impact, embracing the impossible to improve lives everywhere.